Moleculent

Moleculent develops technology for mapping cell-cell communication in human tissue, studying high-plex interactions between receptors and ligands in tissue context. The company states its aim is to uncover insights into cellular biology relevant to diseases such as cancer and neurodegenerative disorders.

The website addresses scientists and life science researchers and describes applications in immunotherapy, where measuring signaling pathways in tumors is presented as a way to understand drug response. An early access program is listed, but the website does not describe pricing or the revenue model.

The leadership page lists a CEO and a CTO, both co-founders, and a board that includes representatives of ARCH Venture Partners. Open roles include a Senior Software Engineer (Python) for life science instrumentation and a Senior System Test Engineer for the instrument platform. The website does not state a founding year or office locations; registry data lists the company in Sweden.

Product: Technology for high-plex mapping of receptor-ligand cell-cell interactions in human tissue, offered in early access; hiring for an instrument platform.